Pharmacological studies of SX-810, a new spasmolytic agent

Clinical pharmacological studies of Kö 1173--a new antiarrhythmic agent.

“Silymarin”, a Promising Pharmacological Agent for Treatment of Diseases

Widespread use of herbal drugs because of their protective effects on different organs toxicity has been shown in many studies. These protective effects have been illustrated in the fields of nephrotoxicity, hepatotoxicity, viral hepatitis, cancer, in vitro fertilization, neurotoxicity, depression, lung diseases, prostate diseases etc. Silymarin has cytoprotection activities due to its antioxid...

Clinico-pharmacological studies and clinical evaluation of flurbiprofen. A new non-steroidal antirheumatic agent.

“silymarin”, a promising pharmacological agent for treatment of diseases

widespread use of herbal drugs because of their protective effects on different organs toxicity has been shown in many studies. these protective effects have been illustrated in the fields of nephrotoxicity, hepatotoxicity, viral hepatitis, cancer, in vitro fertilization, neurotoxicity, depression, lung diseases, prostate diseases etc. silymarin has cytoprotection activities due to its antioxid...

Renal tolerance of cefpirome (HR 810), a new cephalosporin antibiotic.

An open study was carried out in ten healthy, male volunteers in order to investigate the renal tolerance of cefpirome (HR 810), a new cephalosporin antibiotic. Subjects received a single dose of 1.0 g of cefpirome and then repeated doses of 1.0 g of cefpirome twice daily for five days. Urine was collected in several fractions during the study and the urine excretion, excretions of creatinine, ...